Europe’s biggest private biotech company raises $270 mln
Europe’s largest privately held biotech company, Germany-based BioNTech, has raised $270 million to support its work in developing personalised immunotherapies for cancer, ahead of an expected eventual stock market flotation. Overall, the company has brought in close to $950 million since it was founded in 2008 — taking account of initial seed funding, grants and […]
Read More
